Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review

Eur J Obstet Gynecol Reprod Biol. 2019 Apr:235:77-80. doi: 10.1016/j.ejogrb.2019.02.017. Epub 2019 Feb 22.

Abstract

Congenital factor VII deficiency is a rare autosomal recessive disorder associated to different haemorrhagic manifestations. Labour and delivery may cause bleeding risk in patients with this coagulation deficit, thus it is appropriate to clarify whether prophylaxis of peripartum haemorrhage is necessary. To date, there are very few cases in scientific literature which report the management of women with congenital factor VII deficiency during labour, and a consensus for prophylaxis does not exist. In this manuscript we present the management of a 35 years old woman with factor VII deficiency, treated with recombinant factor VIIa before delivery, without haemorrhagic complications either for the woman and for the infant. Therefore, we present a review of similar cases managed with a peripartum prophylaxis with recombinant factor VIIa, and discuss its usefulness and effectiveness, in view of the severity of the deficit and the doses used.

Keywords: Coagulation disorders in pregnancy; Factor VII deficiency; Peripartum haemorrhage; Recombinant factor VIIa.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Factor VII Deficiency / congenital
  • Factor VII Deficiency / drug therapy*
  • Factor VIIa / therapeutic use*
  • Female
  • Hemorrhage / congenital
  • Hemorrhage / prevention & control*
  • Humans
  • Peripartum Period
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy*
  • Pregnancy Complications, Hematologic / prevention & control*
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • recombinant FVIIa
  • Factor VIIa